EncephalX

Sherbrooke, Canada · Founded 2020 · Privately Held (backing)

Developer of cranial implants designed to reduce the risk of complications for patients treated for head trauma, stroke, or subdural hematoma. EncephalX is based in Sherbrooke, Canada and was founded in 2020. Its last reported valuation was $9.6 million in Feb 2026. It has raised $2.7 million.

Last reported valuation
$9.6M
Oct 2026
Priced at
—
Total raised
$2.7M
Last round
—

Who backs EncephalX?

9 investors
InvestorType
Investissement QuebecOther
Front Row VenturesVenture capital
Angels CapitalOther
ACET—
Anges Québec—
Campus des technologies de la santé—
Elevia (Sao Paulo)—
HaloHealth—
Sherbrooke Innopole—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

EncephalX investors

9 investors are on record for EncephalX, including Investissement Quebec, Front Row Ventures, Angels Capital and ACET.

Free account
More of EncephalX with a free account
  • ·Watch EncephalX: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like EncephalX. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View